celecoxib has been researched along with Atherosclerotic Parkinsonism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dassati, S | 1 |
| Schweigreiter, R | 1 |
| Buechner, S | 1 |
| Waldner, A | 1 |
1 other study available for celecoxib and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
Topics: Apolipoproteins D; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Celecoxib; Cell Line | 2021 |